Squarepoint’s F-star Therapeutics, Inc. Common Stock FSTX Stock Holding History

Squarepoint’s Portfolio FSTX Stock Details FSTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-14,888	Closed	-$94.1K	–	3997
2022 Q4	$94.1K	Sell	14,888 -3,805	-20%	-$21.1K	﹤0.01%	2977
2022 Q3	$96K	Buy	+18,693	New	+$117K	﹤0.01%	2802

Squarepoint's FSTX Position: Q1 2023 in Review

Squarepoint sold out of F-star Therapeutics, Inc. Common Stock (FSTX) in Q1 2023, closing a stake of 14,888 shares — an estimated $94.1K sold.

Squarepoint first reported a position in FSTX in Q3 2022 and held it in 2 quarters. The position peaked at $96K in Q3 2022. 0 funds tracked by Wall St. Rank hold FSTX as of Q1 2023.

Squarepoint reported no remaining F-star Therapeutics, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Squarepoint sold 14,888 F-star Therapeutics, Inc. Common Stock shares in Q1 2023, an estimated $94.1K.
Squarepoint first reported a position in F-star Therapeutics, Inc. Common Stock in Q3 2022 and held it in 2 quarters.
Squarepoint's F-star Therapeutics, Inc. Common Stock position peaked at $96K in Q3 2022.
0 funds tracked by Wall St. Rank held F-star Therapeutics, Inc. Common Stock as of Q1 2023.

Based on Squarepoint's 13F filing for Q1 2023, filed 15 May 2023.